Soquelitinib (CPI-818) is an orally active and highly selective covalent interleukin-2-inducible kinase (ITK) inhibitor. Soquelitinib is active in six different models of T cell-mediated inflammatory and immune disease. Soquelitinib increases tumor infiltration of normal CD8+ cells that possess enhanced T effector function.
Molecular Weight:
514.66
Purity:
>99.0%
CAS Number:
[2226636-04-8]
Formula:
C25H30N4O4S2
* VAT and and shipping costs not included. Errors and price changes excepted
